Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 1999

View Archived Issues

Bavarian Nordic Research Institute interim report January-June 1999

1999 half-year highlights at Active Biotech

Positive results for Symlin in phase III study in type II diabetes

Japan Tobacco and Torii to form tie-up in R&D

Antrin photoangioplasty safe and clinically active in PAD therapy

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Millennium extends CNS collaboration with Wyeth-Ayerst

Discovery Therapeutics initiates phase I studies of new cardiac treatment

Pharmacia & Upjohn completes acquisition of Sugen

Preparation, activity and use of piperidine protein farnesyltransferase inhibitors from LG Chemical

International patent covers Darwin Discovery's new PDE4/TNF inhibitors

Cytoclonal makes strides in the design of new anticancer compounds

CRF antagonists in development at Novartis

New Roche compounds enhance tumor delivery of 5-FU

Stanford team develops effective method for topical genetic immunization

Chemokine receptor modulators designed at Merck & Co.

Hydrazone derivatives from Novo Nordisk useful for normalizing glucose levels

Research at St. Charles Pharmaceuticals discussed at ACS

CombiChem presents design and synthesis of selective D4 ligands at ACS meeting

Glaxo Wellcome selects anti-HCMV compound GW-275175X for further study

Inhibitors of MMPs based on D-penicillamine presented by Agouron at ACS meeting

IGT-13, a new and improved etoposide analogue enters the IGT pipeline

More ACS news: preclinical profile of a novel protein farnesyltransferase inhibitor, Sch-207758

Novel antifungal agents targeting fungal prolyl-tRNA synthetase

Potential antiparkinsonian agent emerges from series of subtype-selective NMDA receptor antagonists

Dose-dependent cardioprotective effects of postocclusion ebselen in rabbit model

Ribi's synthetic glycolipid affords sustained cardioprotection in canine infarct model

Avant's sCR1 compounds effective in protecting myocardium in rat model of ischemia-reperfusion

New phenylethanolamine bronchodilators synthesized at Chinese university

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...